Vitamin C reduces blood pressure and improves vascular function

In brief

• Clinical literature indicates that oral vitamin C supplementation can modestly reduce blood pressure in the short term, with average effects around 3–5 mmHg on systolic pressure in various controlled clinical studies.
• Several trials and meta-analyses show improvements in endothelial function (measured with FMD and other tests) after acute or chronic administration of vitamin C.
• Evidence supporting a clinical effect on reducing cardiovascular events remains inconsistent; observational studies show inverse associations between dietary vitamin C and stroke risk, while genetic analyses do not clearly support a direct causal relationship.
• The effects depend on dose, duration, initial risk status, and method (intra-arterial/IV vs oral) and should be interpreted with caution.

Abstract: what does science say?

Vitamin C (ascorbic acid) is a water-soluble micronutrient with biological roles that include antioxidant activity, cofactor stabilization, and support for collagen synthesis. Controlled clinical studies and meta-analyses indicate a modest average reduction in blood pressure after oral supplementation (approximately 3–5 mmHg for systolic pressure). Clinical experiments and mechanistic studies show that vitamin C can increase nitric oxide availability and improve endothelial function, especially in subjects with vascular dysfunction. However, evidence on long-term clinical outcomes (heart attack, stroke) is not consistent; factors such as baseline status, dose, administration route, and duration influence the results. The evidence suggests biological plausibility of a favorable effect on vascularity, but does not unequivocally demonstrate that vitamin C supplementation reduces cardiovascular events in the general population.

Main Section

What is meant by "blood pressure reduction" and why is it relevant?

Blood pressure is an important cardiovascular risk factor: even modest increases in systolic blood pressure are associated with an increased risk of heart attack and stroke in the population. Relatively small reductions, if widespread among many individuals, can have an epidemiological impact on the frequency of cardiovascular events. For this reason, research on nutritional interventions that lower blood pressure by even a few millimeters of mercury is considered relevant from a public health perspective.

What clinical evidence exists on vitamin C and blood pressure?

A meta-analysis of randomized trials conducted across several controlled studies estimated an average reduction in systolic blood pressure of approximately 3.8 mmHg and in diastolic blood pressure of approximately 1.5 mmHg associated with oral vitamin C supplementation (median dose ~500 mg/day). The effect appears more pronounced in subjects with pre-existing hypertension. [1]

Plausible biological mechanisms

Several experimental and clinical studies indicate that vitamin C can improve endothelial function by increasing the availability of nitric oxide (NO), protecting NO from inactivation by free radicals, and stabilizing cofactors for NO synthesis. These effects have been observed both in acute intra-arterial administrations and in chronic oral supplementation in subjects with endothelial dysfunction. [2][3][4][5]

Overall perspective of reviews and aggregated analyses

Systematic reviews and an umbrella analysis of meta-analyses report conflicting results: there are favorable signals on biomarkers (blood pressure, endothelial function, arterial stiffness) in some subgroups, but the evidence on the reduction of major clinical events is limited and not uniform. Methodological quality and study heterogeneity (dose, duration, populations) are critical factors in the overall evaluation. [6][5]

What it means in practice

For the general public: data suggest that improved vitamin C intake — through a diet rich in fruits and vegetables — is associated with benefits for vascular health. The use of supplements for preventive purposes to reduce blood pressure should be evaluated on a case-by-case basis; the average reduction observed in trials is modest and does not replace validated approaches for blood pressure control (healthy lifestyle, weight control, salt reduction, pharmacological therapy when indicated). [1][6]

For healthcare professionals: oral vitamin C supplementation can improve biomarkers of endothelial function and produce small blood pressure reductions, particularly in subjects with hypertension or low vitamin C status. However, studies have not consistently demonstrated benefits on major cardiovascular outcomes; therefore, supplementation cannot be recommended as a first-line strategy for cardiovascular prevention based solely on current evidence. [6][8]

Key takeaways

1. Vitamin C is biologically plausible as a modulator of endothelial function and NO availability.
2. Meta-analyses of RCTs show a modest average reduction in systolic blood pressure (~3–5 mmHg) with oral supplementation. [1]
3. Improvements in endothelial function have been documented in several clinical studies with both acute and chronic administration. [2][3][4][5]
4. Evidence on long-term cardiovascular event reduction is inconsistent; observational and genetic studies provide not entirely consistent results. [6][7][8]
5. The priority remains promoting a diet rich in fruits and vegetables; the use of supplements should be evaluated with clinical care and in an individual context.

Limitations of the Evidence

Difference between observational association and causal proof

Observational studies identify associations between higher intake or circulating levels of vitamin C and a lower risk of stroke or other cardiovascular diseases, but associations do not prove causality: people with healthier diets may differ in many factors that influence cardiovascular risk.

Methodological limitations of trials

Clinical trials often have limited duration, heterogeneous populations, and variable doses; some use non-comparable administration routes (e.g., infusion vs. oral). These aspects complicate the generalization of results and reduce the ability to draw robust conclusions on long-term clinical outcomes. [6]

Contextual variability

The effect of vitamin C appears greater in subjects with endothelial dysfunction, obesity, or low baseline vitamin C status. For the general population with adequate dietary intake, additional benefits from supplements may be minimal. [5][6]

Need for cautious interpretation

Given the mixed evidence, it is appropriate to interpret the results as interesting biological signals but not as definitive proof of clinical efficacy on major events. Longer trials, with clinical endpoints and targeted selection of at-risk populations, are needed to clarify the role of supplementation. [6][8]

Editorial Conclusion

Research on the effects of vitamin C on blood pressure and vascular function has advanced compared to the past and now provides a plausible biological explanation and clinical data indicating modest effects, especially in subjects with hypertension or low plasma vitamin C. However, the evidence does not lead to a universal recommendation for supplementation to prevent cardiovascular events. The priority remains to promote a diet rich in fruits and vegetables and to adopt interventions of proven efficacy for blood pressure control. Decisions on the use of supplements must be personalized and discussed with healthcare professionals in light of the individual risk profile.

Editorial Note

This article is a critical summary of available knowledge and has been updated with reference to the most relevant reviews and studies. It is not intended to replace individual medical advice. For therapeutic decisions or changes in pharmacological therapy, consult your doctor.

SCIENTIFIC RESEARCH

Below are the primary sources cited in the article (numerical order corresponds to citations in the text):

1. Juraschek SP, Guallar E, Appel LJ, Miller ER 3rd. Effects of vitamin C supplementation on blood pressure: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2012;95(5):1079–1088. https://doi.org/10.3945/ajcn.111.027995
2. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation. 1998;97(22):2222–2229. https://doi.org/10.1161/01.CIR.97.22.2222
3. Heitzer T, Just H, Münzel T. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation. 1996;94(1):6–9. https://doi.org/10.1161/01.CIR.94.1.6
4. Van Guilder GP, Hoetzer GL, Greiner JJ, Stauffer BL, DeSouza CA. Acute and chronic effects of vitamin C on endothelial fibrinolytic function in overweight and obese adult humans. J Physiol. 2008;586(14):3525–3535. https://doi.org/10.1113/jphysiol.2008.151555
5. Ashor AW, Lara J, Mathers JC, Siervo M. Effect of vitamin C and vitamin E supplementation on endothelial function: a systematic review and meta-analysis of randomised controlled trials. Br J Nutr. 2015. https://doi.org/10.1017/S0007114515000227
6. Ashor AW, Brown R, Keenan PD, Willis ND, Siervo M, Mathers JC. Limited evidence for a beneficial effect of vitamin C supplementation on biomarkers of cardiovascular diseases: an umbrella review of systematic reviews and meta-analyses. Nutr Res. 2019;61:1–12. https://doi.org/10.1016/j.nutres.2018.08.005
7. Chen GC, Lu DB, Pang Z, Liu QF. Vitamin C intake, circulating vitamin C and risk of stroke: a meta-analysis of prospective studies. J Am Heart Assoc. 2013;2:e000329. https://doi.org/10.1161/JAHA.113.000329
8. Kobylecki CJ, Afzal S, Davey Smith G, Nordestgaard BG. Genetically high plasma vitamin C, intake of fruit and vegetables, and risk of ischemic heart disease and all-cause mortality: a Mendelian randomization study. Am J Clin Nutr. 2015;101:1135–1143. https://doi.org/10.3945/ajcn.114.104497
9. Supplementation With Vitamins C and E Improves Arterial Stiffness and Endothelial Function in Essential Hypertensive Patients. Am J Hypertens. 2007;20(4):392–397. https://doi.org/10.1016/j.amjhyper.2006.09.021